BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23465676)

  • 1. Tailoring esophageal cancer surgery.
    Bronson NW; Luna RA; Hunter JG
    Semin Thorac Cardiovasc Surg; 2012; 24(4):275-87. PubMed ID: 23465676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategy in surgery for esophageal cancer.
    Siewert JR; Hölscher AH
    Ann Ital Chir; 1992; 63(1):13-8. PubMed ID: 1605440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients.
    Gockel I; Sgourakis G; Lyros O; Polotzek U; Schimanski CC; Lang H; Hoppo T; Jobe BA
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):371-84. PubMed ID: 21651355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgery of cancer of the esophagus].
    Triboulet JP
    Rev Prat; 1999 Jun; 49(11):1180-5. PubMed ID: 10416349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An audit of surgical outcomes of esophageal squamous cell carcinoma.
    Goan YG; Chang HC; Hsu HK; Chou YP
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
    Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Esophageal carcinoma: guidelines in surgical therapy].
    Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transhiatal esophagectomy after previous right pneumonectomy.
    Velotta JB; Vasquez CR; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):e150-2. PubMed ID: 24907004
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical management of esophageal carcinoma.
    Reed CE
    Oncologist; 1999; 4(2):95-105. PubMed ID: 10337379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of artificial pneumothorax in semi-prone position to the video-assisted thoracic surgery of esophageal carcinoma].
    Peng L; Han YT; Wang X; Xiao WG; Chen LH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):785-9. PubMed ID: 23291075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
    Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
    Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-related mortality within the first year after subtotal esophagectomy for cancer.
    Pines G; Klein Y; Buyeviz V; Idelevich E; Kashtan H
    Ann Surg Oncol; 2011 Apr; 18(4):1139-44. PubMed ID: 21046267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy.
    Cai WJ; Xin PL
    Radiother Oncol; 2010 Jul; 96(1):104-7. PubMed ID: 20605246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
    Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of neoadjuvant and adjuvant chemotherapy with 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel in the treatment of previously untreated advanced esophageal adenocarcinoma.
    Solomon N; Mezentsev D; Reis I; Lima M; Rios J; Avisar E; Franceschi D; Livingstone A; Podolsky L; Ardalan B
    Jpn J Clin Oncol; 2011 Apr; 41(4):469-76. PubMed ID: 21258083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.